Exponent Inc (EXPO) is a publicly traded Industrials sector company. As of May 20, 2026, EXPO trades at $58.27 with a market cap of $2.78B and a P/E ratio of 26.70. EXPO moved +2.28% today. Year to date, EXPO is -21.03%; over the trailing twelve months it is -26.59%. Its 52-week range spans $51.91 to $115.75. Analyst consensus is strong buy with an average price target of $73.96. Rallies surfaces EXPO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded EXPO stock?
Recent politician trading activity in EXPO includes disclosures from Lisa McClain, Lisa McClain, Jefferson Shreve, and Jefferson Shreve. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
EXPO Key Metrics
Key financial metrics for EXPO
Metric
Value
Price
$58.27
Market Cap
$2.78B
P/E Ratio
26.70
EPS
$2.15
Dividend Yield
0.31%
52-Week High
$115.75
52-Week Low
$51.91
Volume
667.67K
Avg Volume
0
Revenue (TTM)
$602.81M
Net Income
$108.93M
Gross Margin
0.00%
Congressional Trades in EXPO
Lisa McClain sale (full) EXPO on Sep 11, 2025 (amount: $15.00K) for Spouse.
Lisa McClain purchase EXPO on Aug 13, 2025 (amount: $15.00K) for Spouse.
Jefferson Shreve purchase EXPO on Mar 13, 2025 (amount: $50.00K).
Jefferson Shreve purchase EXPO on Feb 24, 2025 (amount: $50.00K).
Recent politician trading activity in EXPO includes disclosures from Lisa McClain, Lisa McClain, Jefferson Shreve, and Jefferson Shreve. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in EXPO?
Yes. Rallies tracks politician and congressional stock disclosures for EXPO, including reported purchases, sales, dates, owners, and trade amounts when available.
Is EXPO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EXPO. It does not provide personalized investment advice.